TABLE 1.
Kaplan-Meier estimates of day 28 (AL and ASAQ) and day 42 (DP) corrected efficacies in previous rounds of therapeutic monitoring in Angolan sentinel sites from 2013 to 2017
| Yr | Reference | Efficacy (%)c
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zaire |
Benguela |
Lunda Sul |
Uígea
|
|||||||||
| AL | ASAQ | DP | AL | ASAQ | DP | AL | ASAQ | DP | AL | DP | ||
| 2013 | 7 | 89.6 | 100b | 97.4 | 100b | |||||||
| 2015 | 8 | 88.1 | 98.8 | 96.3 | 99.9 | 100 | 100 | |||||
| 2017 | 9 | 95.5 | 93.3 | 100 | 100 | 96.5 | 100 | |||||
a
Discontinued as a sentinel site after 2013.
b
Day 28 only.
c
AL, artemether-lumefantrine; ASAQ, artesunate-amodiaquine; DP, dihydroartemisinin-piperaquine.